cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
DA000315 | .l-u | 2 to 492 | 2 to 492 | M52T | capped | 491/491 (100 %) | 1 diff (99.8 %id) | ||
AF143676 | .a | 356 to 1754 | 1 to 1400 | 1400/1403 (99 %) | 2 diff (99.9 %id) | ||||
AK075509 | whole embryo, mainly head | .a | 1 to 1753 | 2 to 1754 | S14P | tiling clone, | 1754/1754 (100 %) | 3 diff (99.9 %id) | |
AK298152 | .f | 1 to 1213 | 3 to 1215 | exact | tiling clone, | 1215/1215 (100 %) | 4 diff (99.7 %id) | ||
AK315190 | placenta | .a | 344 to 1142 | 1 to 799 | 799/799 (100 %) | 0 diff (100 %id) | |||
DA029305 | .l-u | 1 to 558 | 2 to 560 | R47L E48G S50I R51E M52D ... | tiling clone, capped | 559/559 (100 %) | 2 diff (99.7 %id) | ||
AW577340 | breast | .h-u | 1 to 598 | 595 to 1 | L30P L56R | tiling clone, | 595/596 (99 %) | 12 diff (98.0 %id) | |
AW799736 | uterus | .h-u | 237 to 733 | 498 to 3 | 496/518 (95 %) | 0 diff (100 %id) | |||
AW976659 | .h-u | 415 to 998 | 585 to 1 | Submitted on the opposite strand | 585/589 (99 %) | 3 diff (99.5 %id) | |||
AY358411 | .a | 335 to 1752 | 1 to 1418 | 1418/1425 (99 %) | 1 diff (100.0 %id) | ||||
BC039865 | Testis, embryonal carcinoma | .a | 336 to 1753 | 1 to 1418 | tiling clone, available from MGC, AAA | 1418/1418 (100 %) | 0 diff (100 %id) | ||
BF839747 | head_neck | .h-u | 360 to 836 | 477 to 1 | Submitted on the opposite strand | 477/477 (100 %) | 0 diff (100 %id) | ||
BG945369 | amnion_normal | .h-u | 115 to 596 | 1 to 481 | E5V P6S L7G A8P L9E ... | 481/481 (100 %) | 5 diff (99.0 %id) | ||
BI024034 | marrow | .h-u | 721 to 950 | 1 to 231 | 231/231 (100 %) | 14 diff (94.0 %id) | |||
BI024538 | marrow | .a | 770 to 1113 | 1 to 344 | 344/344 (100 %) | 4 diff (98.9 %id) | |||
DA067983 | cerebellum | .l-u | 2 to 557 | 2 to 557 | exact | capped | 556/556 (100 %) | 2 diff (99.7 %id) | |
CD049763 | embryonic stem cells, WA01, passage 38 | .a | 451 to 1310 | 19 to 882 | 864/886 (97 %) | 16 diff (98.2 %id) | |||
CN358959 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .a | 365 to 838 | 1 to 473 | 473/473 (100 %) | 3 diff (99.4 %id) | |||
CN358960 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 342 to 736 | 1 to 395 | 395/395 (100 %) | 6 diff (98.5 %id) | |||
CN358961 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .a | 369 to 921 | 1 to 553 | 553/553 (100 %) | 3 diff (99.5 %id) | |||
CN358962 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .h-u | 112 to 584 | 1 to 473 | exact | 473/473 (100 %) | 0 diff (100 %id) | ||
CN358963 | embryonic stem cells, DMSO-treated H9 cellline | .a | 754 to 1503 | 1 to 750 | 750/750 (100 %) | 1 diff (99.9 %id) | |||
CN358964 | embryonic stem cells, DMSO-treated H9 cellline | .h-u | 500 to 995 | 1 to 496 | 496/496 (100 %) | 6 diff (98.8 %id) | |||
CR592223 | Placenta Cot 25-normalized | .a | 362 to 1738 | 1 to 1377 | 1377/1377 (100 %) | 2 diff (99.9 %id) | |||
CR596567 | Neuroblastoma Cot 25-normalized | .e | 44 to 1433 | 1 to 1390 | exact | tiling clone, | 1390/1390 (100 %) | 2 diff (99.9 %id) | |
CR597197 | Placenta Cot 25-normalized | .a | 341 to 1743 | 1 to 1403 | 1403/1403 (100 %) | 2 diff (99.9 %id) | |||
CR604044 | B cells (Ramos cell line) Cot 25-normalized | .a | 346 to 1723 | 1 to 1378 | 1378/1378 (100 %) | 2 diff (99.9 %id) | |||
CR604619 | neuroblastoma | .e | 20 to 1421 | 1 to 1402 | exact | 1402/1402 (100 %) | 2 diff (99.9 %id) | ||
CR606826 | Neuroblastoma Cot 25-normalized | .h-u | 202 to 1000 | 1 to 799 | 799/799 (100 %) | 1 diff (99.9 %id) | |||
CR608026 | HeLa cells Cot 25-normalized | .a | 345 to 1750 | 1 to 1406 | 1406/1406 (100 %) | 2 diff (99.9 %id) | |||
CR609683 | Neuroblastoma Cot 25-normalized | .f | 18 to 1186 | 1 to 1169 | exact | tiling clone, | 1169/1169 (100 %) | 2 diff (99.9 %id) | |
CR614897 | Neuroblastoma Cot 10-normalized | .a | 364 to 1716 | 1 to 1353 | 1353/1353 (100 %) | 2 diff (99.9 %id) | |||
CR616786 | T cells (Jurkat cell line) Cot10-normalized | .h-u | 510 to 1000 | 1 to 491 | 491/491 (100 %) | 0 diff (100 %id) | |||
CR618359 | Neuroblastoma Cot 10-normalized | .e | 44 to 1417 | 1 to 1374 | exact | 1374/1374 (100 %) | 2 diff (99.9 %id) | ||
CR619257 | neuroblastoma | .a | 462 to 1726 | 1 to 1265 | 1265/1265 (100 %) | 2 diff (99.9 %id) | |||
CR623441 | Neuroblastoma Cot 10-normalized | .a | 374 to 1725 | 1 to 1352 | 1352/1352 (100 %) | 2 diff (99.9 %id) | |||
AL516523 | brain, neuroblastoma, neuroblastoma cells | .a | 687 to 1725 | 1031 to 1 | 1031/1031 (100 %) | 19 diff (98.2 %id) | |||
AL516524 | brain, neuroblastoma, neuroblastoma cells | .e | 20 to 1083 | 1 to 1054 | A168X | 1054/1062 (99 %) | 21 diff (98.1 %id) | ||
BX445517 | neuroblastoma | .e | 20 to 929 | 1 to 909 | W2X P25H P39X P45X A69S ... | 909/909 (100 %) | 22 diff (97.6 %id) | ||
BX438526 | neuroblastoma | .a | 687 to 1721 | 1036 to 1 | 1036/1036 (100 %) | 56 diff (94.6 %id) | |||
BX447254 | neuroblastoma | .a | 750 to 1726 | 976 to 1 | 976/976 (100 %) | 9 diff (99.1 %id) | |||
BX447255 | neuroblastoma | .a | 462 to 1379 | 1 to 917 | 917/917 (100 %) | 1 diff (99.9 %id) | |||
AL521046 | brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized | .a | 1009 to 1724 | 715 to 1 | fully sequenced, | 715/715 (100 %) | 7 diff (99.1 %id) | ||
AL521047 | brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized | .a | 374 to 1039 | 1 to 652 | fully sequenced, | 652/652 (100 %) | 1 diff (99.9 %id) | ||
AL520377 | brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized | .a | 1018 to 1716 | 699 to 1 | fully sequenced, | 699/699 (100 %) | 7 diff (99.0 %id) | ||
AL520378 | brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized | .a | 364 to 1048 | 1 to 672 | fully sequenced, | 672/672 (100 %) | 3 diff (99.6 %id) | ||
AL522626 | brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized | .e | 838 to 1401 | 579 to 16 | fully sequenced, | 564/579 (97 %) | 0 diff (100 %id) | ||
AL522627 | brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized | .e | 44 to 868 | 1 to 824 | W2X D67X L74X R103X | fully sequenced, | 824/824 (100 %) | 1 diff (99.9 %id) | |
AL523530 | brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized | .e | 44 to 1117 | 1 to 1059 | exact | 1059/1090 (97 %) | 19 diff (98.3 %id) | ||
BX329563 | Neuroblastoma Cot 25-normalized | .h-u | 776 to 1001 | 229 to 1 | fully sequenced, | 229/229 (100 %) | 9 diff (96.1 %id) | ||
BX353660 | Neuroblastoma Cot 25-normalized | .h-u | 579 to 1002 | 1 to 424 | tiling clone, fully sequenced, | 424/424 (100 %) | 2 diff (99.6 %id) | ||
BX354079 | Neuroblastoma Cot 25-normalized | .h-u | 247 to 990 | 743 to 1 | fully sequenced, | 743/743 (100 %) | 9 diff (98.8 %id) | ||
BX354080 | Neuroblastoma Cot 25-normalized | .h-u | 202 to 1000 | 1 to 799 | tiling clone, fully sequenced, | 799/799 (100 %) | 1 diff (99.9 %id) | ||
BX354049 | Neuroblastoma Cot 25-normalized | .h-u | 459 to 947 | 503 to 16 | fully sequenced, | 488/503 (97 %) | 0 diff (100 %id) | ||
BX354050 | Neuroblastoma Cot 25-normalized | .h-u | 459 to 998 | 1 to 540 | fully sequenced, | 540/540 (100 %) | 0 diff (100 %id) | ||
BX375665 | Neuroblastoma Cot 25-normalized | .f | 713 to 1186 | 473 to 1 | fully sequenced, | 473/473 (100 %) | 1 diff (99.8 %id) | ||
BX375666 | Neuroblastoma Cot 25-normalized | .f | 18 to 743 | 1 to 726 | D126X H139X | fully sequenced, | 726/726 (100 %) | 1 diff (99.9 %id) | |
BX356707 | Placenta Cot 25-normalized | .a | 1183 to 1743 | 561 to 1 | fully sequenced, | 561/561 (100 %) | 14 diff (97.6 %id) | ||
BX356708 | Placenta Cot 25-normalized | .a | 341 to 1213 | 1 to 858 | G49D W50G L51W A52L A53P ... | fully sequenced, | 858/858 (100 %) | 1 diff (99.9 %id) | |
BX330547 | Placenta Cot 25-normalized | .h-u | 138 to 994 | 861 to 1 | 861/861 (100 %) | 14 diff (98.4 %id) | |||
BX381388 | Placenta Cot 25-normalized | .h-u | 122 to 962 | 842 to 1 | exact | 842/842 (100 %) | 2 diff (99.8 %id) | ||
BX340391 | Placenta Cot 25-normalized | .a | 362 to 955 | 1 to 585 | fully sequenced, | 585/585 (100 %) | 2 diff (99.7 %id) | ||
BX399925 | Placenta Cot 25-normalized | .a | 925 to 1738 | 816 to 1 | fully sequenced, | 816/816 (100 %) | 18 diff (97.8 %id) | ||
BX362393 | .h-u | 510 to 1000 | 1 to 492 | 492/492 (100 %) | 2 diff (99.6 %id) | ||||
BX352533 | .a | 1213 to 1750 | 540 to 1 | fully sequenced, | 540/540 (100 %) | 8 diff (98.6 %id) | |||
BX401249 | .a | 345 to 1243 | 1 to 886 | G49D W50G L51W A52L A53P ... | fully sequenced, | 886/886 (100 %) | 3 diff (99.7 %id) | ||
BX342976 | .a | 1231 to 1722 | 491 to 1 | fully sequenced, | 491/491 (100 %) | 6 diff (98.8 %id) | |||
BX342977 | .a | 346 to 1261 | 1 to 916 | G49D W50G L51W A52L A53P ... | fully sequenced, | 916/916 (100 %) | 7 diff (99.3 %id) | ||
EL734353 | mixed | .a | 354 to 1023 | 1 to 670 | 670/676 (99 %) | 1 diff (99.9 %id) | |||
DC352226 | brain | .e | 18 to 537 | 1 to 521 | 521/521 (100 %) | 2 diff (99.7 %id) | |||
D60301 | brain | .h-u | 643 to 999 | 356 to 1 | 356/356 (100 %) | 2 diff (99.5 %id) | |||
D80689 | brain | .h-u | 309 to 596 | 1 to 284 | 284/284 (100 %) | 17 diff (94.1 %id) | |||
D81048 | brain | .h-u | 651 to 999 | 350 to 1 | fully sequenced, | 350/350 (100 %) | 2 diff (99.5 %id) | ||
D81049 | brain | .h-u | 308 to 681 | 1 to 373 | fully sequenced, | 373/373 (100 %) | 5 diff (98.7 %id) | ||
D81509 | brain | .h-u | 308 to 635 | 1 to 327 | 327/327 (100 %) | 1 diff (99.7 %id) | |||
BY800370 | eye | .a | 368 to 939 | 1 to 572 | 572/572 (100 %) | 0 diff (100 %id) | |||
DA569524 | whole embryo, mainly head | .a | 1 to 454 | 2 to 455 | capped | 454/454 (100 %) | 3 diff (99.4 %id) | ||
DB356168 | whole embryo, mainly head | .a | 1193 to 1753 | 561 to 1 | 561/561 (100 %) | 4 diff (99.3 %id) | |||
N62823 | multiple sclerosis lesions | .h-u | 703 to 1000 | 300 to 1 | fully sequenced, | 300/300 (100 %) | 9 diff (97.0 %id) | ||
W01358 | multiple sclerosis lesions | .h-u | 370 to 733 | 1 to 361 | fully sequenced, | 361/361 (100 %) | 1 diff (99.8 %id) | ||
AA126037 | .a | 1303 to 1554 | 252 to 1 | 252/252 (100 %) | 0 diff (100 %id) | ||||
AA126176 | .a | 342 to 766 | 1 to 409 | 409/409 (100 %) | 19 diff (95.4 %id) | ||||
AA223493 | brain, neuroepithelial cells | .e | 1260 to 1448 | 195 to 8 | tiling clone, | 188/195 (96 %) | 0 diff (100 %id) | ||
AA223646 | brain, neuroepithelial cells | .e | 10 to 205 | 1 to 196 | 196/196 (100 %) | 7 diff (96.5 %id) | |||
AA455168 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 1456 to 1756 | 305 to 5 | tiling clone, | 301/305 (98 %) | 0 diff (100 %id) | ||
AA456543 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 369 to 746 | 1 to 377 | 377/377 (100 %) | 3 diff (99.3 %id) | |||
AA532557 | normal prostatic epithelial cells, Prostate | .h-u | 325 to 712 | 9 to 396 | 388/477 (81 %) | 11 diff (97.7 %id) | |||
AA618528 | normal prostate, Prostate | .h-u | 678 to 999 | 322 to 1 | 322/322 (100 %) | 0 diff (100 %id) | |||
AA641339 | epithelium (cell line), Prostate | .h-u | 644 to 769 | 125 to 1 | 125/125 (100 %) | 1 diff (99.2 %id) | |||
AA653068 | normal prostate, Prostate | .h-u | 715 to 999 | 283 to 1 | 283/283 (100 %) | 4 diff (98.6 %id) | |||
AA742377 | germinal center B cell | .h-u | 510 to 800 | 291 to 1 | 291/291 (100 %) | 0 diff (100 %id) | |||
AA742378 | germinal center B cell | .h-u | 618 to 800 | 183 to 1 | 183/183 (100 %) | 0 diff (100 %id) | |||
AA809741 | germinal center B cell | .h-u | 885 to 999 | 126 to 12 | AAA | 115/115 (100 %) | 0 diff (100 %id) | ||
AA953890 | pooled | .h-u | 688 to 999 | 312 to 1 | 312/373 (83 %) | 1 diff (99.8 %id) | |||
AI001879 | .h-u | 604 to 1001 | 406 to 11 | AAA | 396/396 (100 %) | 2 diff (99.5 %id) | |||
AI221185 | pooled | .h-u | 601 to 997 | 415 to 19 | AAA | 397/397 (100 %) | 1 diff (99.8 %id) | ||
AI422732 | brain, glioblastoma (pooled) | .h-u | 775 to 997 | 223 to 1 | 223/223 (100 %) | 1 diff (99.6 %id) | |||
AI394700 | B-cell, chronic lymphotic leukemia | .h-u | 671 to 998 | 329 to 2 | 328/329 (99 %) | 0 diff (100 %id) | |||
AI521967 | Kidney | .h-u | 574 to 1001 | 441 to 14 | AAA | 428/428 (100 %) | 0 diff (100 %id) | ||
AI623541 | serous papillary carcinoma, high grade, 2pooled tumors, uterus | .h-u | 604 to 800 | 197 to 1 | 197/197 (100 %) | 0 diff (100 %id) | |||
AI654902 | pooled germ cell tumors | .h-u | 669 to 1001 | 344 to 12 | AAA | 333/333 (100 %) | 0 diff (100 %id) | ||
AI720030 | colon | .h-u | 659 to 999 | 341 to 1 | 341/341 (100 %) | 3 diff (99.2 %id) | |||
AI948526 | anaplastic oligodendroglioma, brain | .h-u | 658 to 1001 | 361 to 18 | AAA | 344/344 (100 %) | 3 diff (99.2 %id) | ||
AI971592 | pooled germ cell tumors | .h-u | 660 to 1001 | 354 to 12 | AAA | 343/343 (100 %) | 5 diff (98.6 %id) | ||
AW050660 | serous papillary carcinoma, high grade, 2pooled tumors, uterus | .h-u | 874 to 999 | 126 to 1 | 126/126 (100 %) | 0 diff (100 %id) | |||
AW296724 | .h-u | 601 to 997 | 414 to 18 | AAA | 397/397 (100 %) | 0 diff (100 %id) | |||
AW276188 | lung, two pooled squamous cell carcinomas | .h-u | 599 to 800 | 202 to 1 | 202/202 (100 %) | 0 diff (100 %id) | |||
BE250355 | muscle, rhabdomyosarcoma | .a | 1033 to 1703 | 683 to 1 | fully sequenced, | 683/683 (100 %) | 21 diff (97.0 %id) | ||
BE250532 | muscle, rhabdomyosarcoma | .a | 375 to 1063 | 23 to 706 | fully sequenced, | 684/706 (96 %) | 11 diff (98.5 %id) | ||
BE299300 | muscle, rhabdomyosarcoma | .a | 366 to 1100 | 14 to 752 | 739/854 (86 %) | 24 diff (97.2 %id) | |||
BF515616 | .b | 221 to 533 | 18 to 330 | Submitted on the opposite strand | 313/313 (100 %) | 0 diff (100 %id) | |||
BE328757 | 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney | .h-u | 645 to 800 | 156 to 1 | 156/156 (100 %) | 2 diff (98.8 %id) | |||
BE261392 | brain, neuroblastoma | .a | 355 to 872 | 1 to 517 | 517/517 (100 %) | 1 diff (99.9 %id) | |||
BF475368 | Prostate | .h-u | 760 to 999 | 240 to 1 | 240/240 (100 %) | 1 diff (99.6 %id) | |||
BE257240 | eye, retinoblastoma | .a | 360 to 1024 | 1 to 658 | 658/671 (98 %) | 14 diff (98.0 %id) | |||
BE251256 | eye, retinoblastoma | .a | 396 to 842 | 1 to 447 | 447/450 (99 %) | 1 diff (99.8 %id) | |||
BE548635 | cervical carcinoma cell line, cervix | .b | 1 to 602 | 1 to 601 | tiling clone, | 601/601 (100 %) | 6 diff (99.1 %id) | ||
BE312340 | brain, neuroblastoma | .a | 398 to 976 | 1 to 579 | 579/579 (100 %) | 2 diff (99.7 %id) | |||
BE314446 | brain, neuroblastoma | .a | 374 to 952 | 13 to 594 | 582/594 (97 %) | 10 diff (98.4 %id) | |||
BE294875 | muscle, rhabdomyosarcoma | .a | 385 to 942 | 1 to 557 | 557/557 (100 %) | 1 diff (99.9 %id) | |||
BE297500 | muscle, rhabdomyosarcoma | .a | 373 to 867 | 27 to 521 | 495/522 (94 %) | 6 diff (98.9 %id) | |||
BE266756 | lung, small cell carcinoma | .k | 29 to 717 | 1 to 700 | 700/755 (92 %) | 28 diff (96.3 %id) | |||
BE388023 | endometrium, adenocarcinoma cell line, uterus | .a | 1120 to 1756 | 680 to 18 | Submitted on the opposite strand | 663/704 (94 %) | 0 diff (100 %id) | ||
BE744361 | adenocarcinoma cell line, ovary | .d | 102 to 865 | 1 to 751 | tiling clone, | 751/952 (78 %) | 19 diff (98.1 %id) | ||
BE744966 | adenocarcinoma cell line, ovary | .d | 104 to 851 | 1 to 742 | tiling clone, | 742/743 (99 %) | 11 diff (98.6 %id) | ||
BF033935 | adenocarcinoma, ovary | .d | 28 to 839 | 1 to 800 | 800/864 (92 %) | 53 diff (93.9 %id) | |||
BF037537 | adenocarcinoma, ovary | .h-u | 146 to 825 | 1 to 677 | 677/1000 (67 %) | 19 diff (98.1 %id) | |||
BE782304 | eye, retinoblastoma | .a | 431 to 1099 | 38 to 697 | 660/726 (90 %) | 15 diff (98.0 %id) | |||
BE783998 | eye, retinoblastoma | .a | 407 to 976 | 1 to 577 | 577/577 (100 %) | 9 diff (98.5 %id) | |||
BE909807 | epithelioid carcinoma, Pancreas | .d | 54 to 704 | 1 to 651 | 651/651 (100 %) | 3 diff (99.6 %id) | |||
BE887611 | leiomyosarcoma, uterus | .g | 160 to 914 | 1 to 759 | Q31A V32G Y33I Y34L H35P ... | tiling clone, | 759/862 (88 %) | 22 diff (97.5 %id) | |
BC004509 | Ovary, adenocarcinoma | .a | 730 to 1753 | 1 to 1024 | available from MGC, AAA | 1024/1024 (100 %) | 0 diff (100 %id) | ||
BE747714 | adenocarcinoma cell line, ovary | .a | 730 to 1536 | 29 to 833 | available from MGC, | 805/947 (85 %) | 17 diff (98.3 %id) | ||
BE792687 | lung, small cell carcinoma | .a | 443 to 823 | 1 to 403 | 377/406 (92 %) | 14 diff (96.6 %id) | |||
BE797074 | lung, small cell carcinoma | .a | 444 to 1248 | 1 to 809 | 807/846 (95 %) | 23 diff (97.3 %id) | |||
BE793743 | lung, small cell carcinoma | .k | 57 to 843 | 1 to 778 | tiling clone, | 778/838 (92 %) | 18 diff (97.9 %id) | ||
BE740203 | adenocarcinoma cell line, ovary | .a | 380 to 1072 | 1 to 689 | 689/918 (75 %) | 11 diff (98.9 %id) | |||
BF203284 | muscle, rhabdomyosarcoma | .a | 391 to 1074 | 1 to 673 | 673/912 (73 %) | 13 diff (98.6 %id) | |||
BF207298 | brain, neuroblastoma | .h-u | 350 to 995 | 1 to 652 | 652/849 (76 %) | 18 diff (97.9 %id) | |||
BF304705 | muscle, rhabdomyosarcoma | .a | 365 to 1077 | 1 to 699 | 699/921 (75 %) | 30 diff (96.8 %id) | |||
BF312308 | brain, neuroblastoma | .a | 376 to 1040 | 1 to 658 | 658/945 (69 %) | 18 diff (98.1 %id) | |||
BF314768 | brain, neuroblastoma | .a | 376 to 1172 | 1 to 781 | 781/938 (83 %) | 20 diff (97.9 %id) | |||
BC021260 | Brain, neuroblastoma | .a | 364 to 1751 | 1 to 1388 | available from MGC, AAA | 1388/1388 (100 %) | 0 diff (100 %id) | ||
BF317471 | brain, neuroblastoma | .a | 364 to 1083 | 65 to 775 | available from MGC, | 711/1023 (69 %) | 34 diff (96.7 %id) | ||
BF316892 | brain, neuroblastoma | .a | 377 to 1040 | 1 to 656 | 656/775 (84 %) | 20 diff (97.5 %id) | |||
BF305588 | muscle, rhabdomyosarcoma | .a | 360 to 1085 | 1 to 717 | 717/764 (93 %) | 27 diff (96.5 %id) | |||
BF664470 | B-cells, primary B-cells from tonsils (cell line) | .h-u | 466 to 999 | 24 to 559 | AAA | 536/559 (95 %) | 6 diff (99.0 %id) | ||
BG119882 | adenocarcinoma, cell line, Liver | .a | 345 to 872 | 1 to 534 | 534/535 (99 %) | 19 diff (96.5 %id) | |||
BG256226 | adenocarcinoma, cell line, Prostate | .f | 39 to 694 | 1 to 653 | exact | 653/963 (67 %) | 8 diff (99.2 %id) | ||
BG259043 | embryonal carcinoma, cell line, testis | .d | 12 to 774 | 1 to 762 | 762/870 (87 %) | 14 diff (98.4 %id) | |||
BG393577 | embryonal carcinoma, cell line, testis | .a | 430 to 1223 | 1 to 782 | 782/966 (80 %) | 25 diff (97.5 %id) | |||
BG248395 | adenocarcinoma cell line, colon | .a | 584 to 1166 | 239 to 834 | 591/1150 (51 %) | 50 diff (95.7 %id) | |||
BG327426 | Kidney, renal cell adenocarcinoma | .a | 355 to 983 | 1 to 656 | 584/917 (63 %) | 34 diff (96.3 %id) | |||
BG421947 | Kidney, renal cell adenocarcinoma | .a | 357 to 1000 | 1 to 641 | 641/641 (100 %) | 4 diff (99.4 %id) | |||
BG481162 | choriocarcinoma, placenta | .b | 253 to 1139 | 1 to 890 | tiling clone, | 890/921 (96 %) | 20 diff (97.9 %id) | ||
BG503112 | embryonal carcinoma, testis | .k | 34 to 735 | 1 to 699 | 699/704 (99 %) | 10 diff (98.6 %id) | |||
BG533801 | Liver | .j | 1 to 817 | 1 to 824 | G21V V22S E23G F24V V25R ... | tiling clone, | 824/829 (99 %) | 57 diff (93.2 %id) | |
BG721671 | testis | .a | 196 to 947 | 1 to 752 | 750/753 (99 %) | 24 diff (96.9 %id) | |||
BG744013 | blood, natural killer cells, cell line | .h-u | 207 to 996 | 1 to 793 | fully sequenced, | 793/793 (100 %) | 5 diff (99.4 %id) | ||
BG744673 | blood, natural killer cells, cell line | .h-u | 208 to 945 | 736 to 6 | fully sequenced, | 731/736 (99 %) | 0 diff (100 %id) | ||
BG747504 | adenocarcinoma cell line, colon | .a | 369 to 1066 | 1 to 756 | 663/869 (76 %) | 83 diff (90.5 %id) | |||
BI195956 | brain, neuroblastoma | .e | 47 to 796 | 1 to 743 | 743/745 (99 %) | 15 diff (98.0 %id) | |||
BI198553 | brain, neuroblastoma | .k | 4 to 776 | 1 to 787 | S107L R108T A109G *110L | tiling clone, | 787/787 (100 %) | 28 diff (96.5 %id) | |
BG827250 | muscle, rhabdomyosarcoma | .a | 360 to 1144 | 1 to 787 | 787/787 (100 %) | 21 diff (97.4 %id) | |||
BG829339 | muscle, rhabdomyosarcoma | .a | 391 to 1086 | 1 to 695 | 695/695 (100 %) | 1 diff (99.9 %id) | |||
BG828065 | muscle, rhabdomyosarcoma | .a | 391 to 1261 | 1 to 859 | 859/859 (100 %) | 29 diff (96.7 %id) | |||
BI261498 | lymph, lymphoma, cell line | .a | 358 to 1130 | 1 to 768 | fully sequenced, | 768/768 (100 %) | 14 diff (98.2 %id) | ||
BI262117 | lymph, lymphoma, cell line | .a | 1127 to 1704 | 586 to 4 | fully sequenced, | 583/586 (99 %) | 0 diff (100 %id) | ||
BI333263 | cervical carcinoma cell line, cervix | .a | 370 to 1041 | 1 to 672 | 672/673 (99 %) | 4 diff (99.5 %id) | |||
BI772415 | pooled lung and spleen | .a | 379 to 885 | 1 to 506 | 506/506 (100 %) | 2 diff (99.7 %id) | |||
BI906177 | leukocyte | .k | 8 to 743 | 1 to 737 | tiling clone, | 737/737 (100 %) | 5 diff (99.4 %id) | ||
BI906736 | leukocyte | .a | 366 to 1180 | 1 to 820 | 820/821 (99 %) | 16 diff (98.1 %id) | |||
BI910024 | leukocyte | .a | 352 to 1028 | 1 to 672 | 672/672 (100 %) | 11 diff (98.4 %id) | |||
BI908546 | leukocyte | .a | 366 to 992 | 1 to 626 | 626/626 (100 %) | 1 diff (99.9 %id) | |||
BM008787 | adenocarcinoma, Pancreas | .a | 700 to 1500 | 1 to 803 | 803/803 (100 %) | 2 diff (99.8 %id) | |||
BM008896 | adenocarcinoma, Pancreas | .d | 46 to 845 | 1 to 803 | tiling clone, | 803/803 (100 %) | 10 diff (98.8 %id) | ||
BM008817 | adenocarcinoma, Pancreas | .a | 700 to 1553 | 1 to 868 | 868/868 (100 %) | 64 diff (92.7 %id) | |||
BM020867 | astrocytoma grade IV, cell line, brain | .a | 355 to 1121 | 1 to 760 | 760/761 (99 %) | 18 diff (97.7 %id) | |||
BM020205 | astrocytoma grade IV, cell line, brain | .a | 386 to 1102 | 1 to 714 | 714/906 (78 %) | 14 diff (98.5 %id) | |||
BM020000 | astrocytoma grade IV, cell line, brain | .a | 355 to 1100 | 1 to 745 | 745/745 (100 %) | 3 diff (99.6 %id) | |||
BM908978 | astrocytoma grade IV, cell line, brain | .a | 357 to 862 | 1 to 507 | 507/1308 (38 %) | 14 diff (99.0 %id) | |||
BM045024 | carcinoma, cell line, Prostate | .a | 355 to 1132 | 1 to 778 | 778/779 (99 %) | 7 diff (99.2 %id) | |||
BM049872 | carcinoma, cell line, Prostate | .d | 4 to 606 | 1 to 600 | 600/600 (100 %) | 5 diff (99.2 %id) | |||
BM917173 | blood, natural killer cells, cell line | .i | 1 to 871 | 3 to 880 | tiling clone, | 880/1090 (80 %) | 17 diff (98.5 %id) | ||
BM802859 | embryonal carcinoma, cell line, testis | .d | 116 to 896 | 1 to 782 | tiling clone, | 782/1129 (69 %) | 20 diff (98.3 %id) | ||
BM903651 | ovary (pool of 3) | .a | 345 to 1101 | 1 to 763 | 763/1067 (71 %) | 27 diff (97.5 %id) | |||
BM546889 | ovary (pool of 3) | .h-u | 98 to 995 | 1 to 898 | exact | 898/907 (99 %) | 6 diff (99.4 %id) | ||
BQ053473 | blood, natural killer cells, cell line | .i | 1 to 774 | 3 to 786 | tiling clone, | 786/1123 (69 %) | 23 diff (98.0 %id) | ||
BQ221377 | embryonal carcinoma, cell line, testis | .a | 336 to 1100 | 1 to 772 | 772/858 (89 %) | 8 diff (99.1 %id) | |||
BQ232321 | embryonal carcinoma, cell line, testis | .h-u | 144 to 741 | 1 to 604 | 604/871 (69 %) | 11 diff (98.8 %id) | |||
BQ423358 | embryonal carcinoma, cell line, testis | .d | 19 to 552 | 1 to 534 | 534/542 (98 %) | 21 diff (96.2 %id) | |||
BU159435 | eye, retinoblastoma | .c | 1 to 872 | 1 to 886 | L228T D229* | tiling clone, | 886/886 (100 %) | 28 diff (96.9 %id) | |
BQ959420 | epidermoid carcinoma, cell line, lung | .a | 382 to 1212 | 1 to 841 | 841/894 (94 %) | 11 diff (98.8 %id) | |||
BU541962 | carcinoma, cell line, Prostate | .d | 7 to 655 | 1 to 657 | E120* | 657/1034 (63 %) | 20 diff (98.1 %id) | ||
BU554026 | ovary, teratocarcinoma, cell line | .a | 374 to 990 | 45 to 665 | 621/1047 (59 %) | 25 diff (97.7 %id) | |||
BU931203 | ovary, teratocarcinoma, cell line | .a | 363 to 1100 | 1 to 742 | 742/898 (82 %) | 15 diff (98.4 %id) | |||
BU933770 | mixed (pool of 40 RNAs) | .b | 260 to 1014 | 1 to 773 | tiling clone, | 773/849 (91 %) | 31 diff (96.4 %id) | ||
BU955866 | adenocarcinoma, cell line, breast | .a | 376 to 948 | 1 to 573 | 573/959 (59 %) | 13 diff (98.7 %id) | |||
BU956654 | adenocarcinoma, cell line, breast | .a | 380 to 771 | 1 to 391 | 391/967 (40 %) | 6 diff (99.4 %id) | |||
BU956941 | adenocarcinoma, cell line, breast | .a | 380 to 1221 | 1 to 853 | 853/881 (96 %) | 23 diff (97.4 %id) | |||
CX872519 | embryonic stem | .h-u | 177 to 591 | 415 to 1 | Submitted on the opposite strand | 415/415 (100 %) | 1 diff (99.8 %id) | ||
CV813582 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .a | 380 to 1100 | 1 to 725 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 725/861 (84 %) | 72 diff (91.7 %id) | |
DR760949 | embryonic stem | .a | 350 to 569 | 1 to 220 | 220/220 (100 %) | 2 diff (99.1 %id) | |||
CD514769 | White Matter | .e | 290 to 1114 | 1 to 834 | exact | tiling clone, | 834/865 (96 %) | 10 diff (98.9 %id) | |
DC360142 | .f | 1 to 514 | 3 to 517 | 517/517 (100 %) | 4 diff (99.3 %id) | ||||
DA611691 | .a | 327 to 895 | 2 to 570 | capped | 569/569 (100 %) | 0 diff (100 %id) | |||
TI_57179988 | .a | 379 to 885 | 34 to 539 | 506/539 (93 %) | 8 diff (98.6 %id) | ||||
TI_57231693 | .k | 1 to 743 | 22 to 764 | A2G | 743/764 (97 %) | 10 diff (98.7 %id) | |||
TI_57233182 | .a | 366 to 1180 | 34 to 853 | 820/854 (96 %) | 21 diff (97.6 %id) | ||||
TI_57236011 | .a | 353 to 1028 | 32 to 702 | 671/702 (95 %) | 13 diff (98.2 %id) | ||||
TI_57237217 | .a | 359 to 992 | 26 to 658 | 633/658 (96 %) | 7 diff (99.0 %id) | ||||
TI_59386501 | .a | 700 to 1500 | 106 to 908 | 803/803 (100 %) | 2 diff (99.8 %id) | ||||
TI_59386533 | .a | 700 to 1553 | 60 to 927 | 868/868 (100 %) | 64 diff (92.7 %id) | ||||
TI_59386615 | .d | 47 to 845 | 106 to 907 | 802/802 (100 %) | 9 diff (98.9 %id) | ||||
TI_59387827 | .a | 356 to 1121 | 98 to 856 | 759/760 (99 %) | 17 diff (97.8 %id) | ||||
TI_59390777 | .a | 356 to 1100 | 95 to 838 | 744/744 (100 %) | 2 diff (99.8 %id) | ||||
TI_59390986 | .a | 387 to 1102 | 102 to 814 | 713/905 (78 %) | 13 diff (98.6 %id) | ||||
CB107011 | Liver | .a | 482 to 783 | 1 to 302 | 302/302 (100 %) | 0 diff (100 %id) | |||
CB108709 | Liver | .a | 329 to 757 | 1 to 429 | 429/429 (100 %) | 2 diff (99.6 %id) | |||
CB125686 | Liver | .a | 344 to 878 | 1 to 535 | 535/535 (100 %) | 2 diff (99.7 %id) | |||
CB121534 | Liver | .a | 344 to 521 | 16 to 193 | 178/178 (100 %) | 1 diff (99.5 %id) | |||
CB137012 | Liver | .d | 1 to 462 | 1 to 462 | tiling clone, | 462/462 (100 %) | 0 diff (100 %id) | ||
CB131086 | Liver | .a | 343 to 509 | 1 to 167 | 167/167 (100 %) | 2 diff (98.9 %id) | |||
CB140359 | Liver | .a | 336 to 707 | 1 to 372 | 372/372 (100 %) | 3 diff (99.2 %id) | |||
CB149057 | Liver | .a | 343 to 739 | 1 to 397 | 397/397 (100 %) | 5 diff (98.8 %id) | |||
NM_007243.1 | .a | 336 to 1753 | 1 to 1418 | RefSeq, AAA | 1418/1418 (100 %) | 0 diff (100 %id) | |||
DA844488 | placenta | .a | 345 to 900 | 2 to 557 | capped | 556/556 (100 %) | 0 diff (100 %id) | ||
BM846646 | myeloma | .e | 1 to 602 | 3 to 604 | 604/604 (100 %) | 2 diff (99.7 %id) | |||
BM847576 | myeloma | .e | 1 to 622 | 3 to 624 | tiling clone, | 624/624 (100 %) | 3 diff (99.6 %id) | ||
BM789752 | Ascites, stomach | .g | 1 to 483 | 1 to 483 | tiling clone, | 483/483 (100 %) | 1 diff (99.8 %id) | ||
TI_1948208725 | .a | 353 to 862 | 136 to 646 | fully sequenced, | 511/646 (79 %) | 9 diff (98.7 %id) | |||
TI_1948208726 | .a | 830 to 1148 | 435 to 116 | fully sequenced, | 320/435 (73 %) | 0 diff (100 %id) | |||
TI_1948208895 | .a | 353 to 759 | 123 to 532 | fully sequenced, | 410/532 (77 %) | 7 diff (98.7 %id) | |||
TI_1948208896 | .a | 729 to 1148 | 538 to 119 | fully sequenced, | 420/538 (78 %) | 3 diff (99.5 %id) | |||
TI_1948209063 | .a | 353 to 787 | 128 to 563 | fully sequenced, | 436/563 (77 %) | 6 diff (99.0 %id) | |||
TI_1948209064 | .a | 757 to 1148 | 511 to 120 | fully sequenced, | 392/511 (76 %) | 1 diff (99.9 %id) | |||
TI_1948209230 | .b | 131 to 793 | 786 to 117 | tiling clone, | 668/1266 (52 %) | 50 diff (96.1 %id) | |||
DN996598 | breast cancer, Mammary gland (cancer tissue) | .a | 348 to 905 | 8 to 566 | 559/566 (98 %) | 7 diff (98.8 %id) | |||
BM666750 | eye, human retina | .h-u | 337 to 997 | 680 to 19 | AAA | 662/662 (100 %) | 2 diff (99.7 %id) | ||
BM697698 | eye, fetal eyes | .b | 239 to 759 | 1 to 521 | 521/521 (100 %) | 0 diff (100 %id) | |||
BU735861 | eye, fetal eyes | .b | 1162 to 1396 | 254 to 20 | tiling clone, AAA | 235/235 (100 %) | 1 diff (99.6 %id) | ||
BQ188942 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .h-u | 697 to 997 | 1 to 301 | AAA | 301/301 (100 %) | 0 diff (100 %id) | ||
BM728816 | eye, fetal eye | .h-u | 311 to 987 | 1 to 677 | 677/677 (100 %) | 0 diff (100 %id) | |||
BQ447134 | Knee, Osteoarthritic Cartilage | .h-u | 465 to 997 | 551 to 19 | AAA | 533/533 (100 %) | 12 diff (97.8 %id) | ||
BQ448417 | Knee, Osteoarthritic Cartilage | .h-u | 369 to 999 | 647 to 17 | AAA | 631/631 (100 %) | 0 diff (100 %id) | ||
TI_153963453 | .h-u | 118 to 976 | 83 to 929 | E5D P6A L7S A8W L9P ... | 847/989 (85 %) | 24 diff (97.6 %id) | |||
TI_151733749 | .h-u | 697 to 997 | 378 to 78 | AAA | 301/904 (33 %) | 0 diff (100 %id) | |||
TI_151759765 | .h-u | 311 to 999 | 780 to 92 | AAA | 689/945 (72 %) | 1 diff (99.9 %id) | |||
DB250483 | uterus | .l-u | 2 to 585 | 2 to 585 | exact | tiling clone, capped | 584/584 (100 %) | 1 diff (99.9 %id) | |
AA405544 | .a | 391 to 1261 | 1 to 859 | Suspected internal deletion, this clone was ignored | 859/859 (100 %) | 29 diff (96.7 %id) | |||
AA405598 | .a | 358 to 1130 | 1 to 768 | Suspected internal deletion, this clone was ignored | 768/768 (100 %) | 14 diff (98.2 %id) | |||
AW450747 | .a | 358 to 1130 | 1 to 768 | AAA | Suspected internal deletion, this clone was ignored | 768/768 (100 %) | 14 diff (98.2 %id) | ||
BI262117 | lymph, lymphoma, cell line | .a | 1127 to 1704 | 586 to 4 | fully sequenced, | 583/586 (99 %) | 0 diff (100 %id) | ||
BI262117 | lymph, lymphoma, cell line | .a | 1127 to 1704 | 586 to 4 | fully sequenced, | 583/586 (99 %) | 0 diff (100 %id) | ||
BI333263 | cervical carcinoma cell line, cervix | .a | 370 to 1041 | 1 to 672 | 672/673 (99 %) | 4 diff (99.5 %id) | |||
BI333263 | cervical carcinoma cell line, cervix | .a | 370 to 1041 | 1 to 672 | 672/673 (99 %) | 4 diff (99.5 %id) | |||
BI772415 | pooled lung and spleen | .a | 379 to 885 | 1 to 506 | 506/506 (100 %) | 2 diff (99.7 %id) | |||
BI906177 | leukocyte | .k | 8 to 743 | 1 to 737 | tiling clone, | 737/737 (100 %) | 5 diff (99.4 %id) | ||
BI906736 | leukocyte | .a | 366 to 1180 | 1 to 820 | 820/821 (99 %) | 16 diff (98.1 %id) | |||
BI910024 | leukocyte | .a | 352 to 1028 | 1 to 672 | 672/672 (100 %) | 11 diff (98.4 %id) | |||
BI908546 | leukocyte | .a | 366 to 992 | 1 to 626 | 626/626 (100 %) | 1 diff (99.9 %id) | |||
BM008787 | adenocarcinoma, Pancreas | .a | 700 to 1500 | 1 to 803 | 803/803 (100 %) | 2 diff (99.8 %id) | |||
BM008787 | adenocarcinoma, Pancreas | .a | 700 to 1500 | 1 to 803 | 803/803 (100 %) | 2 diff (99.8 %id) | |||
BM008896 | adenocarcinoma, Pancreas | .d | 46 to 845 | 1 to 803 | tiling clone, | 803/803 (100 %) | 10 diff (98.8 %id) | ||
BM008896 | adenocarcinoma, Pancreas | .d | 46 to 845 | 1 to 803 | tiling clone, | 803/803 (100 %) | 10 diff (98.8 %id) | ||
BM008817 | adenocarcinoma, Pancreas | .a | 700 to 1553 | 1 to 868 | 868/868 (100 %) | 64 diff (92.7 %id) | |||
BM008817 | adenocarcinoma, Pancreas | .a | 700 to 1553 | 1 to 868 | 868/868 (100 %) | 64 diff (92.7 %id) | |||
BM020867 | astrocytoma grade IV, cell line, brain | .a | 355 to 1121 | 1 to 760 | 760/761 (99 %) | 18 diff (97.7 %id) | |||
BM020867 | astrocytoma grade IV, cell line, brain | .a | 355 to 1121 | 1 to 760 | 760/761 (99 %) | 18 diff (97.7 %id) | |||
BM020205 | astrocytoma grade IV, cell line, brain | .a | 386 to 1102 | 1 to 714 | 714/906 (78 %) | 14 diff (98.5 %id) | |||
BM020205 | astrocytoma grade IV, cell line, brain | .a | 386 to 1102 | 1 to 714 | 714/906 (78 %) | 14 diff (98.5 %id) | |||
BM020000 | astrocytoma grade IV, cell line, brain | .a | 355 to 1100 | 1 to 745 | 745/745 (100 %) | 3 diff (99.6 %id) | |||
BM020000 | astrocytoma grade IV, cell line, brain | .a | 355 to 1100 | 1 to 745 | 745/745 (100 %) | 3 diff (99.6 %id) | |||
BM908978 | astrocytoma grade IV, cell line, brain | .a | 357 to 862 | 1 to 507 | 507/1308 (38 %) | 14 diff (99.0 %id) | |||
BM908978 | astrocytoma grade IV, cell line, brain | .a | 357 to 862 | 1 to 507 | 507/1308 (38 %) | 14 diff (99.0 %id) | |||
BM045024 | carcinoma, cell line, Prostate | .a | 355 to 1132 | 1 to 778 | 778/779 (99 %) | 7 diff (99.2 %id) | |||
BM045024 | carcinoma, cell line, Prostate | .a | 355 to 1132 | 1 to 778 | 778/779 (99 %) | 7 diff (99.2 %id) | |||
BM049872 | carcinoma, cell line, Prostate | .d | 4 to 606 | 1 to 600 | 600/600 (100 %) | 5 diff (99.2 %id) | |||
BM049872 | carcinoma, cell line, Prostate | .d | 4 to 606 | 1 to 600 | 600/600 (100 %) | 5 diff (99.2 %id) | |||
BM917173 | blood, natural killer cells, cell line | .i | 1 to 871 | 3 to 880 | tiling clone, | 880/1090 (80 %) | 17 diff (98.5 %id) | ||
BM917173 | blood, natural killer cells, cell line | .i | 1 to 871 | 3 to 880 | tiling clone, | 880/1090 (80 %) | 17 diff (98.5 %id) | ||
BM802859 | embryonal carcinoma, cell line, testis | .d | 116 to 896 | 1 to 782 | tiling clone, | 782/1129 (69 %) | 20 diff (98.3 %id) | ||
BM802859 | embryonal carcinoma, cell line, testis | .d | 116 to 896 | 1 to 782 | tiling clone, | 782/1129 (69 %) | 20 diff (98.3 %id) | ||
BM903651 | ovary (pool of 3) | .a | 345 to 1101 | 1 to 763 | 763/1067 (71 %) | 27 diff (97.5 %id) | |||
BM546889 | ovary (pool of 3) | .h-u | 98 to 995 | 1 to 898 | exact | 898/907 (99 %) | 6 diff (99.4 %id) | ||
BQ053473 | blood, natural killer cells, cell line | .i | 1 to 774 | 3 to 786 | tiling clone, | 786/1123 (69 %) | 23 diff (98.0 %id) | ||
BQ053473 | blood, natural killer cells, cell line | .i | 1 to 774 | 3 to 786 | tiling clone, | 786/1123 (69 %) | 23 diff (98.0 %id) | ||
BQ221377 | embryonal carcinoma, cell line, testis | .a | 336 to 1100 | 1 to 772 | 772/858 (89 %) | 8 diff (99.1 %id) | |||
BQ221377 | embryonal carcinoma, cell line, testis | .a | 336 to 1100 | 1 to 772 | 772/858 (89 %) | 8 diff (99.1 %id) | |||
BQ232321 | embryonal carcinoma, cell line, testis | .h-u | 144 to 741 | 1 to 604 | 604/871 (69 %) | 11 diff (98.8 %id) | |||
BQ232321 | embryonal carcinoma, cell line, testis | .h-u | 144 to 741 | 1 to 604 | 604/871 (69 %) | 11 diff (98.8 %id) | |||
BQ423358 | embryonal carcinoma, cell line, testis | .d | 19 to 552 | 1 to 534 | 534/542 (98 %) | 21 diff (96.2 %id) | |||
BQ423358 | embryonal carcinoma, cell line, testis | .d | 19 to 552 | 1 to 534 | 534/542 (98 %) | 21 diff (96.2 %id) | |||
BU159435 | eye, retinoblastoma | .c | 1 to 872 | 1 to 886 | L228T D229* | tiling clone, | 886/886 (100 %) | 28 diff (96.9 %id) | |
BU159435 | eye, retinoblastoma | .c | 1 to 872 | 1 to 886 | L228T D229* | tiling clone, | 886/886 (100 %) | 28 diff (96.9 %id) | |
BQ959420 | epidermoid carcinoma, cell line, lung | .a | 382 to 1212 | 1 to 841 | 841/894 (94 %) | 11 diff (98.8 %id) | |||
BQ959420 | epidermoid carcinoma, cell line, lung | .a | 382 to 1212 | 1 to 841 | 841/894 (94 %) | 11 diff (98.8 %id) | |||
BU541962 | carcinoma, cell line, Prostate | .d | 7 to 655 | 1 to 657 | E120* | 657/1034 (63 %) | 20 diff (98.1 %id) | ||
BU541962 | carcinoma, cell line, Prostate | .d | 7 to 655 | 1 to 657 | E120* | 657/1034 (63 %) | 20 diff (98.1 %id) | ||
BU554026 | ovary, teratocarcinoma, cell line | .a | 374 to 990 | 45 to 665 | 621/1047 (59 %) | 25 diff (97.7 %id) | |||
BU554026 | ovary, teratocarcinoma, cell line | .a | 374 to 990 | 45 to 665 | 621/1047 (59 %) | 25 diff (97.7 %id) | |||
BU931203 | ovary, teratocarcinoma, cell line | .a | 363 to 1100 | 1 to 742 | 742/898 (82 %) | 15 diff (98.4 %id) | |||
BU931203 | ovary, teratocarcinoma, cell line | .a | 363 to 1100 | 1 to 742 | 742/898 (82 %) | 15 diff (98.4 %id) | |||
BU933770 | mixed (pool of 40 RNAs) | .b | 260 to 1014 | 1 to 773 | tiling clone, | 773/849 (91 %) | 31 diff (96.4 %id) | ||
BU955866 | adenocarcinoma, cell line, breast | .a | 376 to 948 | 1 to 573 | 573/959 (59 %) | 13 diff (98.7 %id) | |||
BU955866 | adenocarcinoma, cell line, breast | .a | 376 to 948 | 1 to 573 | 573/959 (59 %) | 13 diff (98.7 %id) | |||
BU956654 | adenocarcinoma, cell line, breast | .a | 380 to 771 | 1 to 391 | 391/967 (40 %) | 6 diff (99.4 %id) | |||
BU956654 | adenocarcinoma, cell line, breast | .a | 380 to 771 | 1 to 391 | 391/967 (40 %) | 6 diff (99.4 %id) | |||
BU956941 | adenocarcinoma, cell line, breast | .a | 380 to 1221 | 1 to 853 | 853/881 (96 %) | 23 diff (97.4 %id) | |||
BU956941 | adenocarcinoma, cell line, breast | .a | 380 to 1221 | 1 to 853 | 853/881 (96 %) | 23 diff (97.4 %id) | |||
CX872519 | embryonic stem | .h-u | 177 to 591 | 415 to 1 | Submitted on the opposite strand | 415/415 (100 %) | 1 diff (99.8 %id) | ||
CV813582 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .a | 380 to 1100 | 1 to 725 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 725/861 (84 %) | 72 diff (91.7 %id) | |
CV813582 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .a | 380 to 1100 | 1 to 725 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 725/861 (84 %) | 72 diff (91.7 %id) | |
DR760949 | embryonic stem | .a | 350 to 569 | 1 to 220 | 220/220 (100 %) | 2 diff (99.1 %id) | |||
CD514769 | White Matter | .e | 290 to 1114 | 1 to 834 | exact | tiling clone, | 834/865 (96 %) | 10 diff (98.9 %id) | |
DC360142 | .f | 1 to 514 | 3 to 517 | 517/517 (100 %) | 4 diff (99.3 %id) | ||||
DA611691 | .a | 327 to 895 | 2 to 570 | capped | 569/569 (100 %) | 0 diff (100 %id) | |||
TI_57179988 | .a | 379 to 885 | 34 to 539 | 506/539 (93 %) | 8 diff (98.6 %id) | ||||
TI_57231693 | .k | 1 to 743 | 22 to 764 | A2G | 743/764 (97 %) | 10 diff (98.7 %id) | |||
TI_57233182 | .a | 366 to 1180 | 34 to 853 | 820/854 (96 %) | 21 diff (97.6 %id) | ||||
TI_57236011 | .a | 353 to 1028 | 32 to 702 | 671/702 (95 %) | 13 diff (98.2 %id) | ||||
TI_57237217 | .a | 359 to 992 | 26 to 658 | 633/658 (96 %) | 7 diff (99.0 %id) | ||||
TI_59386501 | .a | 700 to 1500 | 106 to 908 | 803/803 (100 %) | 2 diff (99.8 %id) | ||||
TI_59386533 | .a | 700 to 1553 | 60 to 927 | 868/868 (100 %) | 64 diff (92.7 %id) | ||||
TI_59386615 | .d | 47 to 845 | 106 to 907 | 802/802 (100 %) | 9 diff (98.9 %id) | ||||
TI_59387827 | .a | 356 to 1121 | 98 to 856 | 759/760 (99 %) | 17 diff (97.8 %id) | ||||
TI_59390777 | .a | 356 to 1100 | 95 to 838 | 744/744 (100 %) | 2 diff (99.8 %id) | ||||
TI_59390986 | .a | 387 to 1102 | 102 to 814 | 713/905 (78 %) | 13 diff (98.6 %id) | ||||
CB107011 | Liver | .a | 482 to 783 | 1 to 302 | 302/302 (100 %) | 0 diff (100 %id) | |||
CB108709 | Liver | .a | 329 to 757 | 1 to 429 | 429/429 (100 %) | 2 diff (99.6 %id) | |||
CB125686 | Liver | .a | 344 to 878 | 1 to 535 | 535/535 (100 %) | 2 diff (99.7 %id) | |||
CB121534 | Liver | .a | 344 to 521 | 16 to 193 | 178/178 (100 %) | 1 diff (99.5 %id) | |||
CB137012 | Liver | .d | 1 to 462 | 1 to 462 | tiling clone, | 462/462 (100 %) | 0 diff (100 %id) | ||
CB131086 | Liver | .a | 343 to 509 | 1 to 167 | 167/167 (100 %) | 2 diff (98.9 %id) | |||
CB140359 | Liver | .a | 336 to 707 | 1 to 372 | 372/372 (100 %) | 3 diff (99.2 %id) | |||
CB149057 | Liver | .a | 343 to 739 | 1 to 397 | 397/397 (100 %) | 5 diff (98.8 %id) | |||
NM_007243.1 | .a | 336 to 1753 | 1 to 1418 | RefSeq, AAA | 1418/1418 (100 %) | 0 diff (100 %id) | |||
DA844488 | placenta | .a | 345 to 900 | 2 to 557 | capped | 556/556 (100 %) | 0 diff (100 %id) | ||
BM846646 | myeloma | .e | 1 to 602 | 3 to 604 | 604/604 (100 %) | 2 diff (99.7 %id) | |||
BM847576 | myeloma | .e | 1 to 622 | 3 to 624 | tiling clone, | 624/624 (100 %) | 3 diff (99.6 %id) | ||
BM789752 | Ascites, stomach | .g | 1 to 483 | 1 to 483 | tiling clone, | 483/483 (100 %) | 1 diff (99.8 %id) | ||
BM789752 | Ascites, stomach | .g | 1 to 483 | 1 to 483 | tiling clone, | 483/483 (100 %) | 1 diff (99.8 %id) | ||
TI_1948208725 | .a | 353 to 862 | 136 to 646 | fully sequenced, | 511/646 (79 %) | 9 diff (98.7 %id) | |||
TI_1948208726 | .a | 830 to 1148 | 435 to 116 | fully sequenced, | 320/435 (73 %) | 0 diff (100 %id) | |||
TI_1948208895 | .a | 353 to 759 | 123 to 532 | fully sequenced, | 410/532 (77 %) | 7 diff (98.7 %id) | |||
TI_1948208896 | .a | 729 to 1148 | 538 to 119 | fully sequenced, | 420/538 (78 %) | 3 diff (99.5 %id) | |||
TI_1948209063 | .a | 353 to 787 | 128 to 563 | fully sequenced, | 436/563 (77 %) | 6 diff (99.0 %id) | |||
TI_1948209064 | .a | 757 to 1148 | 511 to 120 | fully sequenced, | 392/511 (76 %) | 1 diff (99.9 %id) | |||
TI_1948209230 | .b | 131 to 793 | 786 to 117 | tiling clone, | 668/1266 (52 %) | 50 diff (96.1 %id) | |||
DN996598 | breast cancer, Mammary gland (cancer tissue) | .a | 348 to 905 | 8 to 566 | 559/566 (98 %) | 7 diff (98.8 %id) | |||
DN996598 | breast cancer, Mammary gland (cancer tissue) | .a | 348 to 905 | 8 to 566 | 559/566 (98 %) | 7 diff (98.8 %id) | |||
BM666750 | eye, human retina | .h-u | 337 to 997 | 680 to 19 | AAA | 662/662 (100 %) | 2 diff (99.7 %id) | ||
BM666750 | eye, human retina | .h-u | 337 to 997 | 680 to 19 | AAA | 662/662 (100 %) | 2 diff (99.7 %id) | ||
BM697698 | eye, fetal eyes | .b | 239 to 759 | 1 to 521 | 521/521 (100 %) | 0 diff (100 %id) | |||
BM697698 | eye, fetal eyes | .b | 239 to 759 | 1 to 521 | 521/521 (100 %) | 0 diff (100 %id) | |||
BU735861 | eye, fetal eyes | .b | 1162 to 1396 | 254 to 20 | tiling clone, AAA | 235/235 (100 %) | 1 diff (99.6 %id) | ||
BU735861 | eye, fetal eyes | .b | 1162 to 1396 | 254 to 20 | tiling clone, AAA | 235/235 (100 %) | 1 diff (99.6 %id) | ||
BQ188942 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .h-u | 697 to 997 | 1 to 301 | AAA | 301/301 (100 %) | 0 diff (100 %id) | ||
BQ188942 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .h-u | 697 to 997 | 1 to 301 | AAA | 301/301 (100 %) | 0 diff (100 %id) | ||
BM728816 | eye, fetal eye | .h-u | 311 to 987 | 1 to 677 | 677/677 (100 %) | 0 diff (100 %id) | |||
BM728816 | eye, fetal eye | .h-u | 311 to 987 | 1 to 677 | 677/677 (100 %) | 0 diff (100 %id) | |||
BQ447134 | Knee, Osteoarthritic Cartilage | .h-u | 465 to 997 | 551 to 19 | AAA | 533/533 (100 %) | 12 diff (97.8 %id) | ||
BQ447134 | Knee, Osteoarthritic Cartilage | .h-u | 465 to 997 | 551 to 19 | AAA | 533/533 (100 %) | 12 diff (97.8 %id) | ||
BQ448417 | Knee, Osteoarthritic Cartilage | .h-u | 369 to 999 | 647 to 17 | AAA | 631/631 (100 %) | 0 diff (100 %id) | ||
BQ448417 | Knee, Osteoarthritic Cartilage | .h-u | 369 to 999 | 647 to 17 | AAA | 631/631 (100 %) | 0 diff (100 %id) | ||
TI_153963453 | .h-u | 118 to 976 | 83 to 929 | E5D P6A L7S A8W L9P ... | 847/989 (85 %) | 24 diff (97.6 %id) | |||
TI_151733749 | .h-u | 697 to 997 | 378 to 78 | AAA | 301/904 (33 %) | 0 diff (100 %id) | |||
TI_151759765 | .h-u | 311 to 999 | 780 to 92 | AAA | 689/945 (72 %) | 1 diff (99.9 %id) | |||
DB250483 | uterus | .l-u | 2 to 585 | 2 to 585 | exact | tiling clone, capped | 584/584 (100 %) | 1 diff (99.9 %id) |